stickey-banner-728x90
Cytiva-Banner-800x220
Pharma Focus America
TFS Chemicals - Aspire

Techno Trends

Techno Trends includes advancements and innovations in pharmaceutical products and technology from around the world. Additionally, you may keep abreast of any recent advancements in the pharmaceutical industry (product information and technological trends).

RYBREVANT® Combination Therapy Novel FDA Approval for First-Line Non-Small Cell Lung Cancer Treatment

Johnson & Johnson revealed that the U.S. Food and Drug Administration has granted approval for the use of RYBREVANT® in combination with chemotherapy as a first-line treatment for patients diagnosed...

Novel WINREVAIR™ Receives FDA Approval as First-in-Class Treatment for Adults with Pulmonary Arterial Hypertension

Merck, has announced that the U.S. Food and Drug Administration (FDA) has granted approval for sotatercept-csrk under the brand name WINREVAIR™. ...

UCF Researchers Unveil Revolutionary Treatment for Untreatable Brain Cancer

Researchers at the College of Medicine are pioneering a new approach to combat glioblastoma, an aggressive and currently incurable form of brain cancer. Despite existing treatments such as surgery, radiation, and chemotherapy, patients typically face a grim...

Biogen's SKYCLARYS® Receives Groundbreaking European Commission Approval as the First Treatment for Friedreich’s Ataxia

Biogen recently announced a groundbreaking development: the European Commission has officially authorized SKYCLARYS® for treating Friedreich’s ataxia in adults and adolescents aged 16 years and older. This marks a significant step forward as...

FDA Greenlights Mabwell's Innovative B7-H3 ADC 7MW3711 for Clinical Trials

Mabwell, an innovative biopharmaceutical company boasting a comprehensive industry chain, has received approval from the U.S. Food and Drug Administration for its clinical trial application of a novel B7-H3 targeting ADC, known as 7MW3711. This ADC,...

Iovance's Groundbreaking AMTAGVI™ (Lifileucel) Secures Accelerated FDA Approval to Revolutionize Advanced Melanoma Therapy

Iovance Biotherapeutics has gained approval from the U.S. Food and Drug Administration for AMTAGVI™ suspension for intravenous infusion. This treatment is tailored for adults facing unresectable or metastatic melanoma...

FDA Approves Mabwell's Innovative Novel B7-H3 ADC 7MW3711 targeting for Clinical Trials

Mabwell, an innovative biopharmaceutical company boasting a comprehensive industry chain, has received approval from the U.S. Food and Drug Administration for its clinical trial application of a novel B7-H3...

Bayer's novel BAY 2927088 Granted FDA Breakthrough Status for HER2-Driven Non-Small Cell Lung Cancer

Bayer made a recent announcement stating that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation for BAY 2927088. This designation is for the treatment of adult patients...

Neurologists at IU Administer received FDA-Approval for First-of-Its-Kind Gene Therapy

Neurologists at the Indiana University School of Medicine have commenced administering a pioneering gene-based therapy for individuals afflicted with a rare variant of amyotrophic lateral sclerosis...

UTEP Researchers Discover Novel Compound with Anti-Leukemia and Anti-Lymphoma Properties

Researchers at The University of Texas at El Paso have identified a groundbreaking pharmaceutical compound that shows promise in eliminating leukemia and lymphoma cancer cells, offering potential advancements in treatment options...

Sartorius - 6th Edition Live-Cell Imagingpatheon - Mastering API production at every scaleWorld Vaccine Congress Europe 2024World Orphan Drug Congress 2024Future Labs Live USA 2024Interphex 2024patheon - Revolutionizing PharmaHealthcare CNO SummitHealthcare CMO SummitThe Healthcare Patient Experience & Engagement SummitHealthcare Innovation & Transformation SummitmRNA-stillF-PharmaFocusUS-300x600